Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FULC Fulcrum Therapeutics

已收盘 04-22 16:00:00 EDT

3.65

+0.19

+5.49%

盘后3.53

-0.12-3.29%

19:31 EDT

最高3.87	最低3.47	成交量58.37万
今开3.47	昨收3.46	日振幅11.56%
总市值1.97亿	流通市值9,674万	总股本5,398万
成交额215.43万	换手率2.20%	流通股本2,650万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FULC","market":"US","secType":"STK","nameCN":"Fulcrum Therapeutics","latestPrice":3.65,"timestamp":1745352000000,"preClose":3.46,"halted":0,"volume":583705,"hourTrading":{"tag":"盘后","latestPrice":3.53,"preClose":3.65,"latestTime":"19:31 EDT","volume":1588,"amount":5782.84,"timestamp":1745364687542},"delay":0,"floatShares":26503051,"shares":53979306,"eps":-0.156895,"marketStatus":"已收盘","change":0.19,"latestTime":"04-22 16:00:00 EDT","open":3.47,"high":3.87,"low":3.47,"amount":2154292.184564,"amplitude":0.115607,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.156895,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":5,"adr":0,"listingDate":1563422400000,"exchange":"NASDAQ","adjPreClose":3.46,"preHourTrading":{"tag":"盘前","latestPrice":2.82,"preClose":3.46,"latestTime":"04:43 EDT","volume":110,"amount":323.200009,"timestamp":1745311438176},"postHourTrading":{"tag":"盘后","latestPrice":3.53,"preClose":3.65,"latestTime":"19:31 EDT","volume":1588,"amount":5782.84,"timestamp":1745364687542},"volumeRatio":2.046007,"impliedVol":1.032,"impliedVolPercentile":0.656},"requestUrl":"/m/hq/s/FULC","defaultTab":"news","newsList":[{"id":"2527419568","title":"Fulcrum Therapeutics, Inc.盘中异动 大幅拉升5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527419568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527419568?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:34","pubTimestamp":1744641292,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时34分，Fulcrum Therapeutics, Inc.股票出现波动，股价大幅拉升5.58%。截至发稿，该股报2.84美元/股，成交量3.9127万股，换手率0.07%，振幅4.09%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Third Harmonic Bio, Inc.、Theratechnologies Inc.、Metsera, Inc.涨幅较大，Artelo Biosciences, Inc.、Aditxt, Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为595.49%、313.93%、153.65%，振幅较大的相关个股有Artelo Biosciences, Inc.、Theratechnologies Inc.、Fate Therapeutics, Inc.，振幅分别为48.91%、29.90%、24.99%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041422345294d51633&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041422345294d51633&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","FULC"],"gpt_icon":0},{"id":"2518797203","title":"Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.41%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518797203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518797203?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:02","pubTimestamp":1741626172,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时02分，Fulcrum Therapeutics, Inc.股票出现异动，股价大幅下挫5.41%。截至发稿，该股报2.97美元/股，成交量14.2611万股，换手率0.26%，振幅4.33%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为4138.96%、3793.09%、981.72%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为88.14%、78.32%、54.65%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311010252964060a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311010252964060a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2516677389","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大跌5.56%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677389?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:40","pubTimestamp":1741099209,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时40分，Fulcrum Therapeutics, Inc.股票出现波动，股价大幅下跌5.56%。截至发稿，该股报3.06美元/股，成交量8270股，换手率0.02%，振幅1.08%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1106.78%、1100.10%、436.25%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Windtree Therapeutics, Inc.，振幅分别为37.67%、22.25%、19.21%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224009a25f0785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224009a25f0785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC","BK4007","BK4139"],"gpt_icon":0},{"id":"2516376038","title":"Fulcrum Therapeutics, Inc.2024财年实现净利润-9.73百万美元，同比增加90.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516376038?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:01","pubTimestamp":1740758461,"startTime":"0","endTime":"0","summary":"3月1日，Fulcrum Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-9.73百万美元，同比增加90.00%；其中营业收入为80.00百万美元，同比增加2746.98%，每股基本收益为-0.16美元。机构评级：截至2025年3月1日，当前有6家机构对Fulcrum Therapeutics, Inc.目标价做出预测，其中目标均价为5.67美元，其中最低目标价为2.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000155a258185d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000155a258185d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","LENZ"],"gpt_icon":0},{"id":"2514906570","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘股价大跌5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514906570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514906570?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:33","pubTimestamp":1740494027,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时33分，Fulcrum Therapeutics, Inc.股票出现异动，股价快速下跌5.95%。截至发稿，该股报3.48美元/股，成交量9438股，换手率0.02%，振幅4.59%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为760.67%、470.72%、244.50%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Dominari Holdings Inc.，振幅分别为20.51%、14.67%、11.73%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223347a253879e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223347a253879e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"1132526931","title":"福尔克姆治疗公司第四季度GAAP每股亏损$(0.31)，好于预期的$(0.32)","url":"https://stock-news.laohu8.com/highlight/detail?id=1132526931","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132526931?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:30","pubTimestamp":1740486651,"startTime":"0","endTime":"0","summary":"福尔克姆治疗公司报告季度每股亏损$，好于分析师预期的$，超出预期3.13%。相比去年同期每股亏损$，这是22.5%的增长。以上内容来自Benzinga Earnings专栏，原文如下：$Fulcrum Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 3.13 percent. This is a 22.5 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"福尔克姆治疗公司第四季度GAAP每股亏损$(0.31)，好于预期的$(0.32)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FULC"],"gpt_icon":0},{"id":"2514609364","title":"Fulcrum Therapeutics(FULC.US)：2024年Q4财报实现营收0美元，前值为87.1万美元；每股收益为-0.31美元，前值为-0.40美元，预期值为-0.29美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514609364","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514609364?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:11","pubTimestamp":1740485514,"startTime":"0","endTime":"0","summary":"Fulcrum Therapeutics(FULC.US)：2024年Q4财报实现营收0美元，前值为87.1万美元；每股收益为-0.31美元，前值为-0.40美元，预期值为-0.29美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25201148381039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","FULC"],"gpt_icon":0},{"id":"2503396586","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘快速下跌5.49%报4.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503396586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503396586?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:36","pubTimestamp":1736778990,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时36分，Fulcrum Therapeutics, Inc.股票出现异动，股价急速下挫5.49%。截至发稿，该股报4.13美元/股，成交量1.1376万股，换手率0.02%，振幅4.12%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3508.04%、2126.83%、393.32%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、61.54%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223630a22040ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223630a22040ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","FULC"],"gpt_icon":0},{"id":"2500912386","title":"Fulcrum Therapeutics, Inc.盘中异动 急速拉升5.17%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500912386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500912386?lang=zh_cn&edition=full","pubTime":"2025-01-04 03:19","pubTimestamp":1735931999,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日03时19分，Fulcrum Therapeutics, Inc.股票出现波动，股价急速拉升5.17%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Scorpius Holdings, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1807.19%、1706.52%、337.93%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.，振幅分别为143.91%、123.70%、107.01%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104032000a214a1af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104032000a214a1af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","FULC","LENZ"],"gpt_icon":0},{"id":"2495526426","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495526426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495526426?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:35","pubTimestamp":1735569346,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时35分，Fulcrum Therapeutics, Inc.股票出现波动，股价大幅下挫5.01%。截至发稿，该股报4.55美元/股，成交量4.42万股，换手率0.08%，振幅4.70%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vincerx Pharma, Inc.、Polyrizon Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Polyrizon Ltd.、Vincerx Pharma, Inc.较为活跃，换手率分别为690.36%、330.51%、108.55%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Vincerx Pharma, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为52.75%、43.40%、38.72%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223546ab98272d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223546ab98272d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","FULC"],"gpt_icon":0},{"id":"2494988385","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘股价大跌5.78%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494988385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494988385?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:31","pubTimestamp":1735309864,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时31分，Fulcrum Therapeutics, Inc.股票出现波动，股价急速跳水5.78%。截至发稿，该股报4.56美元/股，成交量4.3608万股，换手率0.08%，振幅3.72%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Evaxion Biotech As、Serina Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Nucana Plc较为活跃，换手率分别为66.79%、24.25%、14.26%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Evaxion Biotech As、Armata Pharmaceuticals, Inc.，振幅分别为38.73%、15.35%、7.92%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122722310495ef7427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122722310495ef7427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC","BK4139","BK4007"],"gpt_icon":0},{"id":"2494894814","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494894814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494894814?lang=zh_cn&edition=full","pubTime":"2024-12-27 03:49","pubTimestamp":1735242558,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日03时49分，Fulcrum Therapeutics, Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报4.78美元/股，成交量46.4472万股，换手率0.86%，振幅5.93%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Moolec Science Sa C/Wts 、Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为2211.35%、478.30%、119.28%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Scisparc Ltd.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为264.57%、198.24%、131.78%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227034918a20ad4e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227034918a20ad4e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","FULC","BK4139"],"gpt_icon":0},{"id":"2493423927","title":"Fulcrum Therapeutics, Inc.盘中异动 急速上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493423927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493423927?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:06","pubTimestamp":1734710775,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时06分，Fulcrum Therapeutics, Inc.股票出现异动，股价急速拉升5.21%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Aptose Biosciences, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2316.07%、176.30%、84.61%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.，振幅分别为173.15%、147.88%、92.48%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100061595ea9e1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100061595ea9e1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","FULC"],"gpt_icon":0},{"id":"2492102675","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492102675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492102675?lang=zh_cn&edition=full","pubTime":"2024-12-20 02:07","pubTimestamp":1734631653,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日02时07分，Fulcrum Therapeutics, Inc.股票出现异动，股价急速跳水5.20%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.59%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Psyence Biomedical Ltd.、Elevai Labs, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为7998.64%、615.47%、491.29%，振幅较大的相关个股有Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为396.08%、248.84%、185.71%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220020734984cdc65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220020734984cdc65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2491692770","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘大幅拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692770?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:48","pubTimestamp":1734360488,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时48分，Fulcrum Therapeutics, Inc.股票出现波动，股价大幅拉升5.30%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Viridian Therapeutics, Inc.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为42.27%、32.80%、30.78%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为38.10%、19.33%、19.23%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224808ab7c9ca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224808ab7c9ca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","FULC"],"gpt_icon":0},{"id":"2490872173","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490872173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490872173?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:07","pubTimestamp":1734016055,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时07分，Fulcrum Therapeutics, Inc.股票出现波动，股价快速跳水5.00%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Palisade Bio, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Trevi Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3045.22%、756.04%、65.77%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Palisade Bio, Inc.，振幅分别为75.86%、71.35%、56.43%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212230735984b9845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212230735984b9845&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FULC","BK4007"],"gpt_icon":0},{"id":"2490773811","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.21%报4.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490773811","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490773811?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:33","pubTimestamp":1733754810,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时33分，Fulcrum Therapeutics, Inc.股票出现异动，股价大幅上涨5.21%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为2430.16%、23.78%、19.98%，振幅较大的相关个股有Rapport Therapeutics, Inc.、Passage Bio, Inc.、Nkgen Biotech, Inc.，振幅分别为106.84%、105.41%、104.58%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223330a1e0a935&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223330a1e0a935&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2489214963","title":"Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489214963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489214963?lang=zh_cn&edition=full","pubTime":"2024-12-05 03:44","pubTimestamp":1733341440,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日03时44分，Fulcrum Therapeutics, Inc.股票出现异动，股价大幅跳水5.04%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Exicure, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为4639.59%、283.99%、144.55%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为548.98%、287.57%、64.57%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205034400a1d45213&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205034400a1d45213&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","FULC"],"gpt_icon":0},{"id":"2488468209","title":"Fulcrum Therapeutics, Inc.盘中异动 快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488468209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488468209?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:41","pubTimestamp":1733236899,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时41分，Fulcrum Therapeutics, Inc.股票出现波动，股价大幅跳水5.15%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Janux Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为132.67%、76.28%、60.87%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.、Senti Biosciences, Inc.，振幅分别为51.13%、24.09%、23.90%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224139abf2fe03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224139abf2fe03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FULC","LENZ","BK4007"],"gpt_icon":0},{"id":"2486351868","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486351868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486351868?lang=zh_cn&edition=full","pubTime":"2024-11-27 03:45","pubTimestamp":1732650303,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日03时45分，Fulcrum Therapeutics, Inc.股票出现波动，股价快速拉升5.23%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Poseida Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，木薯科学、Elevai Labs, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为57.12%、52.10%、34.32%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Lakeshore Biopharma Co., Ltd，振幅分别为85.82%、57.50%、55.39%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127034504abe141e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127034504abe141e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FULC","LENZ","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fulcrumtx.com","stockEarnings":[{"period":"1week","weight":0.1849},{"period":"1month","weight":0.0984},{"period":"3month","weight":-0.135},{"period":"6month","weight":0.0646},{"period":"1year","weight":-0.4942},{"period":"ytd","weight":-0.2638}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fulcrum Therapeutics, Inc.于2015年8月18日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于在高度未满足的医疗需求领域改善基因定义疾病患者的生活，最初的重点是罕见病。该公司开发了一种专有产品引擎，该公司使用该引擎来系统地识别和验证细胞药物靶点，这些靶点可以潜在地调节基因表达，以治疗已知的基因定义疾病的根本原因。该公司正在使用产品引擎来识别可以被小分子下药的靶点，而不管基因错误表达的特定潜在机制如何。该公司已确定药物靶点，以治疗面肩肱肌营养不良症（FSHD）和某些血红蛋白病（即镰状细胞病（SCD））和b-地中海贫血的根本原因。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.052045},{"month":2,"riseRate":0.5,"avgChangeRate":-0.009687},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.014346},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.124566},{"month":5,"riseRate":0.6,"avgChangeRate":0.060108},{"month":6,"riseRate":0.4,"avgChangeRate":-0.04331},{"month":7,"riseRate":0.6,"avgChangeRate":0.083911},{"month":8,"riseRate":0.5,"avgChangeRate":0.487567},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.171434},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.105879},{"month":11,"riseRate":0.833333,"avgChangeRate":0.258816},{"month":12,"riseRate":1,"avgChangeRate":0.213611}],"exchange":"NASDAQ","name":"Fulcrum Therapeutics","nameEN":"Fulcrum Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fulcrum Therapeutics(FULC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fulcrum Therapeutics,FULC,Fulcrum Therapeutics股票,Fulcrum Therapeutics股票老虎,Fulcrum Therapeutics股票老虎国际,Fulcrum Therapeutics行情,Fulcrum Therapeutics股票行情,Fulcrum Therapeutics股价,Fulcrum Therapeutics股市,Fulcrum Therapeutics股票价格,Fulcrum Therapeutics股票交易,Fulcrum Therapeutics股票购买,Fulcrum Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fulcrum Therapeutics(FULC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}